Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Huaijin Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6425-3019; OpenAlex author ID A5109761051. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Pancreatic cancer cells escape T/NK cell immune surveillance through the expressional separation of CD58. First author DOI 10.1136/jitc-2025-012163↗
  2. Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy. Co-author DOI 10.1186/s12943-024-02184-8↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Quan Liao · 2 shared papers, 2024–2025 · strength 0.44
  2. Qiaofei Liu · 2 shared papers, 2024–2025 · strength 0.44
  3. Jorg H. Kleeff · 2 shared papers, 2024–2025 · strength 0.44
  4. Yalu Zhang · 1 shared paper, 2025 · strength 0.26
  5. Sen Yang · 1 shared paper, 2025 · strength 0.26
  6. Ronghua Zhang · 1 shared paper, 2025 · strength 0.26
  7. Xudong Liu · 1 shared paper, 2024 · strength 0.18
  8. Yupei Zhao · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.